Beyond Batten Disease Foundation
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.beyondbatten.org
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)An Open-label Safety, Pharmacokinetic, and Efficacy Study of Miglustat for the Treatment of CLN3 Disease
- First Posted Date
- 2021-12-30
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- Beyond Batten Disease Foundation
- Target Recruit Count
- 6
- Registration Number
- NCT05174039
- Locations
- 🇺🇸
Texas Children Hospital, Houston, Texas, United States
News
No news found